Researchers from Cambridge University have developed a new method for predicting the progression of Alzheimer’s disease (AD), which promises 80% accuracy.

BrainSee is designed to predict the likelihood of progression from MCI to Alzheimer’s dementia within 5 years, allowing doctors and patients to make informed decisions early.

This new AI Alzheimer’s detection model was trained on the transcribed speech of 166 older adults diagnosed with mild cognitive impairment (MCI), a condition that often precedes Alzheimer’s.

Discover how a new AI tool can predict Alzheimer's with 80% accuracy, transforming early diagnosis and patient care. ... which are crucial in managing Alzheimer’s and slowing its progression.

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250425113453.htm ...

Get Instant Summarized Text (Gist) The plasma biomarker p-tau217, measurable through a blood test, enables early prediction of Alzheimer's disease progression, including in asymptomatic individuals.

When the researchers tested NCT-503 in two mouse models of Alzheimer’s disease, they saw that it significantly alleviated Alzheimer’s progression. The treated mice demonstrated substantial ...